MALROT: Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus.

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT05148429
Collaborator
(none)
30
1
22
1.4

Study Details

Study Description

Brief Summary

Digestive malrotation is an anatomical anomaly of the positionning of the mesenteric vessels and the digestive tract that can lead in some form to a dangerous neonatal complication: intestinal volvulus. This requires emergency surgery with a risk of digestive resection. Visualizing during pregnancy the normal or abnormal anatomical positionning of the mesenteric vessels could make it possible to diagnose this malrotation and prevent the occurrence of this complication.

The aim of the study is to study the neonatal outcome of fetus confirm to have an abnormal positionning of mesenteric vessels

Condition or Disease Intervention/Treatment Phase
  • Other: Ultrasound exam
  • Other: Fetal MRI
  • Other: Postnatal abdominal ultrasound
  • Other: Pediatric Follow up

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus: Value of the Ultrasound Study of the Relative Position of the Superior Mesenteric Vessels and Fetal Abdominal MRI.
Actual Study Start Date :
Jan 1, 2020
Actual Primary Completion Date :
Oct 1, 2021
Actual Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Fetuses with abnormal positionning of mesenteric vessels

All pregnant women with abnormal positionning of mesenteric vessels during second trimester scan

Other: Ultrasound exam
Ultrasound exam

Other: Fetal MRI
Fetal MRI

Other: Postnatal abdominal ultrasound
Postnatal abdominal ultrasound

Other: Pediatric Follow up
Pediatric Follow up

Outcome Measures

Primary Outcome Measures

  1. Percentage of intestinal malrotation among foetuses [day 1]

    Percentage of intestinal malrotation among foetuses with abnormal positionning of mesenteric vessels

Secondary Outcome Measures

  1. Rate of correlation between prenatal [day 1]

    Rate of correlation between prenatal

  2. Rate of postnatal ultrasound [day 1]

    Rate of postnatal ultrasound

  3. type of intestinal malrotation [day 1]

    type of intestinal malrotation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Pregnant women attending for 2nd trimester ultrasound

  • Abnormal positionning of mesenteric vessels

  • No other foetal malformation

  • Singleton pregnancy

  • Age >18 years

Exclusion criteria:
  • Chromosomal abnormality

  • polymalformative syndrom

  • Foetal malformation changing intestine disposition (gastroschisis, diaphragmatic hernia, heterotaxis…)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uhmontpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Florent FUCHS, PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT05148429
Other Study ID Numbers:
  • RECHMPL21_0684
First Posted:
Dec 8, 2021
Last Update Posted:
Dec 23, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2021